Jinzhang Chen

924 total citations
32 papers, 380 citations indexed

About

Jinzhang Chen is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Jinzhang Chen has authored 32 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 14 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Jinzhang Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Jinzhang Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Jinzhang Chen collaborates with scholars based in China, United Kingdom and United States. Jinzhang Chen's co-authors include Mengya Zang, Guosheng Yuan, Rongcheng Luo, Xiao Hu, Xiao Cheng, Yabing Guo, Xiaoxiang Rong, Wei Huang, Wencong Dai and Wenxuan Yu and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Jinzhang Chen

31 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinzhang Chen China 10 143 116 106 90 75 32 380
Jonathan Kessler United States 9 121 0.8× 160 1.4× 98 0.9× 60 0.7× 32 0.4× 41 389
Taek Chung South Korea 11 54 0.4× 106 0.9× 77 0.7× 86 1.0× 78 1.0× 28 381
Chaonong Cai China 10 80 0.6× 121 1.0× 56 0.5× 107 1.2× 94 1.3× 20 332
Lindy K. Alles Netherlands 10 64 0.4× 71 0.6× 88 0.8× 96 1.1× 77 1.0× 16 351
Tomoya Kawase Japan 6 140 1.0× 103 0.9× 44 0.4× 47 0.5× 39 0.5× 22 298
Banghao Xu China 10 57 0.4× 115 1.0× 71 0.7× 94 1.0× 51 0.7× 30 328
Pai‐Chi Teng United States 7 143 1.0× 173 1.5× 89 0.8× 239 2.7× 215 2.9× 15 506

Countries citing papers authored by Jinzhang Chen

Since Specialization
Citations

This map shows the geographic impact of Jinzhang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinzhang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinzhang Chen more than expected).

Fields of papers citing papers by Jinzhang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinzhang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinzhang Chen. The network helps show where Jinzhang Chen may publish in the future.

Co-authorship network of co-authors of Jinzhang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jinzhang Chen. A scholar is included among the top collaborators of Jinzhang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinzhang Chen. Jinzhang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Rong, Wenli Li, Qing Yang, et al.. (2025). Low‐Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma. Liver International. 45(4). e70066–e70066. 2 indexed citations
2.
Li, Ruofan, Tianzhun Wu, Liqun Xu, et al.. (2025). Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis. BMC Genomics. 26(1). 493–493.
3.
4.
Yuan, Guosheng, Qiong Deng, Yan Wang, et al.. (2024). Cadonilimab (PD-1/CTLA-4) in combination with lenvatinib in unresectable hepatocellular carcinoma (uHCC): A retrospective real-world study. Heliyon. 10(19). e37616–e37616. 4 indexed citations
5.
6.
7.
Shen, Yifei, Shuaishuai Xu, Chanqi Ye, et al.. (2023). Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma. iScience. 26(2). 106003–106003. 10 indexed citations
8.
Ruan, Jian, Shuaishuai Xu, Qiong Li, et al.. (2022). EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma. Briefings in Bioinformatics. 23(6). 8 indexed citations
9.
10.
11.
Li, Qi, Guosheng Yuan, Xiao Cheng, et al.. (2022). Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. Frontiers in Oncology. 12. 809709–809709. 28 indexed citations
12.
13.
14.
Pan, Changqie, Jianhua Wu, Siting Zheng, et al.. (2021). Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β 2 ‐AR/MACC1 axis. Cancer Communications. 41(10). 1049–1070. 38 indexed citations
15.
Yuan, Guosheng, Qi Li, Xiao Hu, et al.. (2021). Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients. Frontiers in Immunology. 11. 613946–613946. 61 indexed citations
16.
Liu, Feiye, Xiaoxiang Rong, Jinzhang Chen, et al.. (2017). MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer. Molecular Cancer. 16(1). 122–122. 60 indexed citations
17.
Rong, Xiaoxiang, Xiaoli Cai, Rong Li, et al.. (2014). Positron emission tomography‐computed tomography on predicting the efficacy of targeted therapy for lung adenocarcinoma. Thoracic Cancer. 5(4). 297–303. 5 indexed citations
18.
Chen, Jinzhang, et al.. (2012). Fluorescence examination and photodynamic therapy of facial squamous cell carcinoma—A case report. Photodiagnosis and Photodynamic Therapy. 9(1). 87–90. 5 indexed citations
19.
Zuo, Qiang, Min Shi, Jinzhang Chen, & Wangjun Liao. (2011). The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma. Biomedicine & Pharmacotherapy. 65(3). 168–174. 9 indexed citations
20.
Chen, Jinzhang, et al.. (2010). Effect of bevacizumab combined with FOLFOX4 on advanced colorectal cancer. Zhongguo redai yixue. 10(11). 1393–1394. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Kessler Breakdown of academic impact, for papers by Taek Chung Breakdown of academic impact, for papers by Chaonong Cai Breakdown of academic impact, for papers by Lindy K. Alles Breakdown of academic impact, for papers by Tomoya Kawase Breakdown of academic impact, for papers by Banghao Xu Breakdown of academic impact, for papers by Pai‐Chi Teng
Rankless by CCL
2026